These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 25172422

  • 1. ASK1 pharmacophore model derived from diverse classes of inhibitors.
    Starosyla SA, Volynets GP, Bdzhola VG, Golub AG, Protopopov MV, Yarmoluk SM.
    Bioorg Med Chem Lett; 2014 Sep 15; 24(18):4418-4423. PubMed ID: 25172422
    [Abstract] [Full Text] [Related]

  • 2. Rational design of apoptosis signal-regulating kinase 1 inhibitors: discovering novel structural scaffold.
    Volynets GP, Bdzhola VG, Golub AG, Synyugin AR, Chekanov MA, Kukharenko OP, Yarmoluk SM.
    Eur J Med Chem; 2013 Mar 15; 61():104-15. PubMed ID: 23041041
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors.
    Lovering F, Morgan P, Allais C, Aulabaugh A, Brodfuehrer J, Chang J, Coe J, Ding W, Dowty H, Fleming M, Frisbie R, Guzova J, Hepworth D, Jasti J, Kortum S, Kurumbail R, Mohan S, Papaioannou N, Strohbach JW, Vincent F, Lee K, Zapf CW.
    Eur J Med Chem; 2018 Feb 10; 145():606-621. PubMed ID: 29348070
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of novel ASK1 inhibitors using virtual screening.
    Okamoto M, Saito N, Kojima H, Okabe T, Takeda K, Ichijo H, Furuya T, Nagano T.
    Bioorg Med Chem; 2011 Jan 01; 19(1):486-9. PubMed ID: 21134755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The redox-active site of thioredoxin is directly involved in apoptosis signal-regulating kinase 1 binding that is modulated by oxidative stress.
    Psenakova K, Hexnerova R, Srb P, Obsilova V, Veverka V, Obsil T.
    FEBS J; 2020 Apr 01; 287(8):1626-1644. PubMed ID: 31623019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival.
    Eaton GJ, Zhang QS, Diallo C, Matsuzawa A, Ichijo H, Steinbeck MJ, Freeman TA.
    Cell Death Dis; 2014 Nov 13; 5(11):e1522. PubMed ID: 25393478
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors.
    Fujisawa T.
    Adv Biol Regul; 2017 Dec 13; 66():85-90. PubMed ID: 29066277
    [Abstract] [Full Text] [Related]

  • 20. Aryl amide derivatives of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives useful as ASK1 inhibitors, an evaluation of WO2012080735.
    Norman P.
    Expert Opin Ther Pat; 2012 Dec 13; 22(12):1479-83. PubMed ID: 22917158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.